Dapidran, Edrian .

HRN: 09-34-27  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/24/2024
CEFUROXIME 750MG (VIAL)
11/24/2024
11/30/2024
IV
750mg
Q8
AGE, URTI
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaIntra-abdominal    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: